Perinatal depression management: A narrative review of guidelines and recommendations in chosen European countries

European Journal of Midwifery · 2026 · Europe

Source and licence

Authors
Kornelia Bartoszewicz, Ewa Sowa, Edyta Szurowska et al.
Title
Perinatal depression management: A narrative review of guidelines and recommendations in chosen European countries
Journal
European Journal of Midwifery, 2026
Licence
CC BY 4.0
Changes
Verbatim excerpts; formatting adapted

Full text retrieved 2026-10-27 from Europe PMC · PMC13573179

Licence statement of the original publication

This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License.

This page reproduces excerpts of the original publication; the original is authoritative. It has not been reviewed by a physician, does not state a recommendation of Medelix and does not replace medical advice. The guideline may have been updated since.

This is a review of another guideline (National perinatal depression screening and treatment guidelines in 15 European countries, European national guidelines (15 countries) 2025). We do not reproduce that guideline's recommendations here – they belong to the original guideline.

Open the original publication →Full text on Europe PMC

Abstract

Perinatal depression (PND) is a mood disorder occurring during pregnancy or within a year after childbirth, affecting up to 12% of women. Given its prevalence and burden, effective national strategies for screening and treatment are essential for its mitigation. This is a narrative review that examines current approaches to managing PND across fifteen European countries with a focus on the availability of national guidelines for screening in order to identify gaps in maternal mental health and recommend feasible solutions based on examples from countries implementing effective programs. The guidelines were identified through searches in PubMed, Scopus, EMBASE, general web search engines, and websites of national healthcare institutions by two independent reviewers conducting the search. Guidelines were included only if they were officially issued or endorsed by national authorities, applied nationwide, and provided specific procedures and tools for screening.

Among the fifteen countries examined, only four had national guidelines addressing both screening and treatment, and two had guidelines focused solely on treatment. Our evidence also indicates growing interest in PND, with several countries enhancing parental mental healthcare through pilot initiatives. International programs like the EU’s Riseup-PPD and the PATH project sought to strengthen perinatal mental healthcare by supporting healthcare professionals and researchers. Despite the lack of national guidelines in some countries, NGOs have created comprehensive materials and national versions of screening tools.

Stronger engagement from national health authorities is essential to ensure women receive adequate, timely care. Obligatory, standardized screening must be implemented alongside training for healthcare professionals.

Contents of the original publication

The section headings of the original.

  • INTRODUCTION
  • COMMENTARY
  • Availability of national guidelines
  • International programs
  • Content of recommendations
  • Guidelines versus reality
  • Role of non-governmental organizations
  • Implications
  • Limitations
  • CONCLUSION
  • ETHICAL APPROVAL AND INFORMED CONSENT
  • PROVENANCE AND PEER REVIEW

A question about this guideline?

Medelix answers clinical questions from guidelines and studies – every statement with its source.

Are you the rights holder and object to this reproduction? Write to contact@medelix.ai and we will take the page down promptly. Imprint